P21 - Treatment with Glucocorticoids and Fragility Fractures

Autor Gioia, M., Grasso, M., Gimigliano, F., Iolascon, G.
Vydáno 2010

Neuropsychiatric Disorders in Hip Fracture Patients

Autor Iolascon, G., Cervone, M., Di Pietro, G., Gimigliano, F.
Vydáno 2010

Epidemiology of Fragility Fractures

Autor Piscitelli, P., Tarantino, U., Iolascon, G., Brandi, M.L.
Vydáno 2010

P22 - Cognitive Impairment in Hip Fracture Patients

Autor Tirelli, A., D’Amico, M.P., Gimigliano, F., Iolascon, G.
Vydáno 2010

Efficacy of a Single Intra-Articular HYMOVIS ONE Injection for Managing Symptomatic Hip Osteoarthritis: A 12-Month Follow-Up Retrospective Analysis of the ANTIAGE Register Data

Autor Migliore A, Frediani B, Gigliucci G, Foti C, Crimaldi S, De Lucia O, Iolascon G
Vydáno 2020-03-01

How can the orthopedic surgeon ensure optimal vitamin D status in patients operated for an osteoporotic fracture?

Autor Chevalley, T., Brandi, M.L., Cavalier, E., Harvey, N.C., Iolascon, G., Cooper, C., Hannouche, D., Kaux, J.-F., Kurth, A., Maggi, S., Maier, G., Papavasiliou, K., Al-Daghri, N., Sosa-Henríquez, M., Suhm, N., Tarantino, U., Reginster, J.-Y., Rizzoli, R.
Vydáno v Osteoporos Int (2021)